CCR4 receptor antagonists (Astellas)

N/A

Report date: 2025/06/11 10:33:27
NME

Base Information

Drug NameCCR4 receptor antagonists (Astellas)
Drug Alias NameCCR4 receptor antagonist (Astellas)AS-191711AS-1917911AS-1917910AS-191710 +[6] 
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 4 antagonists
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsInflammationAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A